Clearside Biomedical, Inc. (CLSD)

Clearside Biomedical Market Cap

Clearside Biomedical has a market cap or net worth of $97.88 million as of April 19, 2024. Its market cap has increased by 43.74% in one year.

• Market Cap: 97.88M
• Enterprise Value: 111.97M
• 1-Year Change: 43.74%
• Ranking: #4119
• Category: Micro-Cap
• Stock Price: $1.31

Market Cap Chart

Since June 2, 2016, Clearside Biomedical's market cap has decreased from $142.00M to $97.88M, a decrease of -31.07%. That is a compound annual growth rate of -4.61%.

Market Cap History

Date	Market Cap	% Change
Apr 18, 2024	98.60M	4.78%
Apr 17, 2024	94.10M	9.55%
Apr 16, 2024	85.90M	-10.89%
Apr 15, 2024	96.40M	3.21%
Apr 12, 2024	93.40M	-3.81%
Apr 11, 2024	97.10M	4.75%
Apr 10, 2024	92.70M	-3.84%
Apr 9, 2024	96.40M	-
Apr 8, 2024	96.40M	-0.72%
Apr 5, 2024	97.10M	-2.31%
Apr 4, 2024	99.40M	-7.02%
Apr 3, 2024	106.90M	2.20%
Apr 2, 2024	104.60M	-11.43%
Apr 1, 2024	118.10M	3.32%
Mar 28, 2024	114.30M	-8.41%
Mar 27, 2024	124.80M	-1.19%
Mar 26, 2024	126.30M	-2.32%
Mar 25, 2024	129.30M	1.17%
Mar 22, 2024	127.80M	-4.98%
Mar 21, 2024	134.50M	10.43%
Mar 20, 2024	121.80M	-
Mar 19, 2024	121.80M	4.46%
Mar 18, 2024	116.60M	-8.76%
Mar 15, 2024	127.80M	-1.16%
Mar 14, 2024	129.30M	6.16%

View and export this data all the way back to 2016. Sign Up Today.

Related Stocks

Company	Market Cap
Anixa Biosciences	97.29M
Genelux	97.12M
Elicio Therapeutics	95.06M
Seres Therapeutics	94.73M
Oramed Pharmaceuticals	94.41M
Curis	94.01M
Allakos	93.15M
Milestone Pharmaceuticals	93.01M